3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests

TORONTO — A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.